Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Baxter
QuintilesIMS
Chubb
Accenture
Healthtrust
Harvard Business School
Boehringer Ingelheim
Colorcon
Cerilliant

Generated: August 23, 2017

DrugPatentWatch Database Preview

LIQUAEMIN SODIUM PRESERVATIVE FREE Drug Profile

« Back to Dashboard

What is the patent landscape for Liquaemin Sodium Preservative Free, and what generic Liquaemin Sodium Preservative Free alternatives are available?

Liquaemin Sodium Preservative Free is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in LIQUAEMIN SODIUM PRESERVATIVE FREE is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: LIQUAEMIN SODIUM PRESERVATIVE FREE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list11,246
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIQUAEMIN SODIUM PRESERVATIVE FREE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc
LIQUAEMIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION000552-011Apr 11, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION000552-012Apr 11, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Organon Usa Inc
LIQUAEMIN SODIUM PRESERVATIVE FREE
heparin sodium
INJECTABLE;INJECTION000552-013Apr 11, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Citi
Dow
AstraZeneca
Cantor Fitzgerald
Daiichi Sankyo
Cipla
Chinese Patent Office
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot